143 related articles for article (PubMed ID: 35585014)
21. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
[TBL] [Abstract][Full Text] [Related]
22. Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study.
Kim SH; Lee DE; Joung JY; Seo HK; Lee KH; Chung J
Investig Clin Urol; 2020 Mar; 61(2):146-157. PubMed ID: 32158965
[TBL] [Abstract][Full Text] [Related]
23. The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy.
Yu X; Wang B; Li X; Lin G; Zhang C; Yang Y; Fang D; Song Y; He Z; Zhou L
Biomed Res Int; 2015; 2015():176373. PubMed ID: 26568955
[TBL] [Abstract][Full Text] [Related]
24. The impact of metastasectomy on survival of patients with synchronous metastatic renal cell cancer in Finland: A nationwide study.
Laru L; Ronkainen H; Ohtonen P; Vaarala MH
Scand J Surg; 2024 Mar; ():14574969241234485. PubMed ID: 38433655
[TBL] [Abstract][Full Text] [Related]
25. Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry.
Kim JK; Kim SH; Song MK; Joo J; Seo SI; Kwak C; Jeong CW; Song C; Hwang EC; Seo IY; Lee H; Hong SH; Park JY; Chung J
Cancer Res Treat; 2019 Apr; 51(2):758-768. PubMed ID: 30189720
[TBL] [Abstract][Full Text] [Related]
26. Retrospective survival analysis of 237 consecutive patients with multiple pulmonary metastases from advanced renal cell carcinoma exclusively resected by a 1318-nm laser.
Baier B; Kern A; Kaderali L; Bis B; Koschel D; Rolle A
Interact Cardiovasc Thorac Surg; 2015 Aug; 21(2):211-7. PubMed ID: 25977131
[TBL] [Abstract][Full Text] [Related]
27. Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.
Sun M; Meyer CP; Karam JA; de Velasco G; Chang SL; Pal SK; Trinh QD; Choueiri TK
Eur J Surg Oncol; 2018 Sep; 44(9):1439-1445. PubMed ID: 29935840
[TBL] [Abstract][Full Text] [Related]
28. Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies.
Antoun S; Lanoy E; Iacovelli R; Albiges-Sauvin L; Loriot Y; Merad-Taoufik M; Fizazi K; di Palma M; Baracos VE; Escudier B
Cancer; 2013 Sep; 119(18):3377-84. PubMed ID: 23801109
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes and prognostic factors following the surgical resection of renal cell carcinoma spinal metastases.
Kato S; Demura S; Murakami H; Yoshioka K; Shinmura K; Yokogawa N; Shimizu T; Kawahara N; Tsuchiya H
Cancer Sci; 2021 Jun; 112(6):2416-2425. PubMed ID: 33780597
[TBL] [Abstract][Full Text] [Related]
30. Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma.
Laukhtina E; Pradere B; D'Andrea D; Rosiello G; Luzzago S; Pecoraro A; Palumbo C; Knipper S; Karakiewicz PI; Margulis V; Quhal F; Sari Motlagh R; Mostafaei H; Mori K; Schuettfort VM; Enikeev D; Shariat SF
Minerva Urol Nephrol; 2022 Jun; 74(3):329-336. PubMed ID: 33769012
[TBL] [Abstract][Full Text] [Related]
31. Spinal metastasectomy of renal cell carcinoma: A 16-year single center experience with a minimum 3-year follow-up.
Kato S; Murakami H; Demura S; Nambu K; Fujimaki Y; Yoshioka K; Kawahara N; Tomita K; Tsuchiya H
J Surg Oncol; 2016 Apr; 113(5):587-92. PubMed ID: 26846902
[TBL] [Abstract][Full Text] [Related]
32. Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma.
Eggener SE; Yossepowitch O; Kundu S; Motzer RJ; Russo P
J Urol; 2008 Sep; 180(3):873-8; discussion 878. PubMed ID: 18635225
[TBL] [Abstract][Full Text] [Related]
33. Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib.
Martini DJ; Kline MR; Liu Y; Shabto JM; Carthon BC; Russler GA; Yantorni L; Hitron EE; Caulfield S; Goldman JM; Harris WB; Kucuk O; Master VA; Bilen MA
Cancer Treat Res Commun; 2021; 28():100393. PubMed ID: 34029879
[TBL] [Abstract][Full Text] [Related]
34. Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review.
Ouzaid I; Capitanio U; Staehler M; Wood CG; Leibovich BC; Ljungberg B; Van Poppel H; Bensalah K;
Eur Urol Oncol; 2019 Mar; 2(2):141-149. PubMed ID: 31017089
[TBL] [Abstract][Full Text] [Related]
35. Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Zaid HB; Parker WP; Safdar NS; Gershman B; Erwin PJ; Murad MH; Boorjian SA; Costello BA; Thompson RH; Leibovich BC
J Urol; 2017 Jan; 197(1):44-49. PubMed ID: 27473875
[TBL] [Abstract][Full Text] [Related]
36. International Multi-institutional Characterization of the Perioperative Morbidity of Metastasectomy for Renal Cell Carcinoma.
Lyon TD; Roussel E; Sharma V; Carames G; Lohse CM; Costello BA; Boorjian SA; Thompson RH; Joniau S; Albersen M; Leibovich BC
Eur Urol Oncol; 2023 Feb; 6(1):76-83. PubMed ID: 36509653
[TBL] [Abstract][Full Text] [Related]
37. Pushing the limits of metastasis-directed treatment in metastatic renal cell carcinoma in the era of targeted therapy.
Holz S; Tosco L; Akand M; Verbiest A; Beuselinck B; Albersen M; Roussel E; Van Poppel H; Joniau S
Urol Oncol; 2020 Dec; 38(12):937.e1-937.e9. PubMed ID: 32900628
[TBL] [Abstract][Full Text] [Related]
38. Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Donskov F; Xie W; Overby A; Wells JC; Fraccon AP; Sacco CS; Porta C; Stukalin I; Lee JL; Koutsoukos K; Yuasa T; Davis ID; Pezaro C; Kanesvaran R; Bjarnason GA; Sim HW; Rathi N; Kollmannsberger CK; Canil CM; Choueiri TK; Heng DYC
Eur Urol Oncol; 2020 Aug; 3(4):530-539. PubMed ID: 32037304
[TBL] [Abstract][Full Text] [Related]
39. External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study.
Okita K; Hatakeyama S; Naito S; Numakura K; Kato R; Koguchi T; Kojima T; Kawasaki Y; Kandori S; Kawamura S; Nishiyama H; Ito A; Kojima Y; Habuchi T; Obara W; Tsuchiya N; Ohyama C
Urol Oncol; 2021 Dec; 39(12):836.e11-836.e17. PubMed ID: 34544649
[TBL] [Abstract][Full Text] [Related]
40. Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis.
Grassi P; Doucet L; Giglione P; Grünwald V; Melichar B; Galli L; De Giorgi U; Sabbatini R; Ortega C; Santoni M; Bamias A; Verzoni E; Derosa L; Studentova H; Pacifici M; Coppa J; Mazzaferro V; de Braud F; Porta C; Escudier B; Procopio G
PLoS One; 2016; 11(4):e0151662. PubMed ID: 27064898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
